Status: current, Defined. Date: 31-Oct 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2097241000168119 | hydrochlorothiazide 12.5 mg + irbesartan 150 mg tablet, 98 tablets (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2097251000168117 | irbesartan 150 mg + hydrochlorothiazide 12.5 mg tablet, 98 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| irbesartan 150 mg + hydrochlorothiazide 12.5 mg tablet, 98 | Is a | irbesartan 150 mg tablet, 98 | true | Inferred relationship | Some | ||
| irbesartan 150 mg + hydrochlorothiazide 12.5 mg tablet, 98 | has MPUU | irbesartan 150 mg + hydrochlorothiazide 12.5 mg tablet | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Irbesartan HCT 150/12.5 (Sanofi) (hydrochlorothiazide 12.5 mg + irbesartan 150 mg) tablet, 98 tablets (trade product pack) | Is a | True | irbesartan 150 mg + hydrochlorothiazide 12.5 mg tablet, 98 | Inferred relationship | Some | |
| Irbesartan HCTZ 150 mg/12.5 mg (Apotex) tablet, 98 | Is a | True | irbesartan 150 mg + hydrochlorothiazide 12.5 mg tablet, 98 | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR